Search Results for 'breast expression'

breast expression published presentations and documents on DocSlides.

Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer
Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer
by isabella2
Gavin Buckley. Supervisor: . Dr.. Malgorzata . Kr...
WNT5A and Breast Cancer Group 1:
WNT5A and Breast Cancer Group 1:
by calandra-battersby
Matthew Beatty, Brynn Cullander, Melissa Frank, ...
What’s Positive about Triple Negative Breast Cancer
What’s Positive about Triple Negative Breast Cancer
by myesha-ticknor
What’s Positive about Triple Negative Breast Ca...
Evaluation of HR[ER/
Evaluation of HR[ER/
by debby-jeon
PgR. ] status and correlation with Ki67 expres...
Evaluation of HR[ER/ PgR
Evaluation of HR[ER/ PgR
by pasty-toler
] status and correlation with Ki67 expression ...
Ecadherin is a transmembrane glycoprotein which has been shown to me
Ecadherin is a transmembrane glycoprotein which has been shown to me
by melody
187 as well as with the advanced stages of a wider...
B V Anuradha Devi S Chandra Sekhar C Saritha S Sanhya Anil H
B V Anuradha Devi S Chandra Sekhar C Saritha S Sanhya Anil H
by amber
in invasive breast carcinoma . IAIM, 2016; 3(6 ): ...
ReviewIntroductionBreast cancer is the type of cancer with the highest
ReviewIntroductionBreast cancer is the type of cancer with the highest
by delcy
Eur J Breast Health 2017; 13: 168-74 ABSTRACTBreas...
Abstract Background Bones belong to the most frequentlocalizations o
Abstract Background Bones belong to the most frequentlocalizations o
by bery
215 Correspondence to: : Fas/Fas-ligand inBreast C...
BREASTFEEDING PROTOCOL
BREASTFEEDING PROTOCOL
by gabriella
Expressing, Collecting, and NAME ROLE AND/OR LOC...
Proteomics of Tissue Tropism in Breast
Proteomics of Tissue Tropism in Breast
by heartfang
Cancer (mostly). Lauren Barney. Peyton Lab. March ...
Insulin-like Growth Factor Binding Protein 5 (IGFBP5) as
Insulin-like Growth Factor Binding Protein 5 (IGFBP5) as
by liane-varnes
a putative biomarker for breast . cancer risk. 20...
Molecular Biology of Cancer AND
Molecular Biology of Cancer AND
by mitsue-stanley
Cancer Informatics (omics). David Boone. Outline....
Molecular Biology of Cancer AND
Molecular Biology of Cancer AND
by pasty-toler
Cancer Informatics (omics). David Boone. Outline....
SHINING A LIGHT ON THE GENOME’S ‘DARK MATTER’
SHINING A LIGHT ON THE GENOME’S ‘DARK MATTER’
by summer
NON-CODING RNAs (. nc. RNAs) : MICRORNAs AND CANC...
Gene expression patterns of breast carcinomas distingu
Gene expression patterns of breast carcinomas distingu
by min-jolicoeur
Perou ad Robert Tibshirani Turid Aas Stephanie Ge...
Translating NGS Data into a Clinically Actionable Assay
Translating NGS Data into a Clinically Actionable Assay
by danika-pritchard
Elaine R. Mardis, Ph.D.. Professor of Genetics. C...
Case It workshop:  integrating molecular biology computer
Case It workshop:  integrating molecular biology computer
by pamella-moone
Mark . Bergland. and Karen . Klyczek. Universi...
Dysregulation
Dysregulation
by kittie-lecroy
of the miR-34a-SIRT1 axis inhibits breast. cance...
Genomic Characterization of Invasive Lobular Breast Carcinoma
Genomic Characterization of Invasive Lobular Breast Carcinoma
by funname
Michael L. Gatza, Ph.D.. TCGA Breast Cancer AWG. I...
Novel peptide based gene delivery vehicle   Proven capability for deli
Novel peptide based gene delivery vehicle Proven capability for deli
by ariel
Figure 1: RALA nanoparticles are formulated simply...
Breastfeeding without NursingExclusive PumpingMarsha Walker RN IBCLCMa
Breastfeeding without NursingExclusive PumpingMarsha Walker RN IBCLCMa
by rodriguez
10/24/2019Breastfeeding but not at the breast85 of...
Therefore there is an urgent demand to identify new more effective
Therefore there is an urgent demand to identify new more effective
by evelyn
68 Abstract.OBJECTIVE: Breast cancer metastasis su...
BRMS1 interacts with LSD1CoREST complex
BRMS1 interacts with LSD1CoREST complex
by amey
2041 Am J Cancer Res 2018;8(10):2030-2045 Figure 6...